Rajesh MBA - Ajanta Pharma Joint Director
AJANTPHARM | 3,027 30.05 1.00% |
Director
Rajesh MBA is Joint Director of Ajanta Pharma Limited
Age | 48 |
Address | Ajanta House, Mumbai, India, 400067 |
Phone | 91 22 6606 1000 |
Web | https://www.ajantapharma.com |
Ajanta Pharma Management Efficiency
The company has return on total asset (ROA) of 0.1531 % which means that it generated a profit of $0.1531 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2445 %, meaning that it generated $0.2445 on every $100 dollars invested by stockholders. Ajanta Pharma's management efficiency ratios could be used to measure how well Ajanta Pharma manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Ajanta Pharma's Total Current Assets are increasing as compared to previous years.Similar Executives
Found 14 records | DIRECTOR Age | ||
Anil Sharma | Sarveshwar Foods Limited | 47 | |
Amit Gandhi | Vertoz Advertising Limited | 37 | |
Mahadeep Jamwal | Sarveshwar Foods Limited | 71 | |
Satnam Arora | Kohinoor Foods Limited | 75 | |
Harbans Lal | Sarveshwar Foods Limited | 56 | |
Arjuun Guuha | ADF Foods Limited | N/A | |
Gaurav Modi | Vertoz Advertising Limited | 39 | |
Surendar Jasrotia | Sarveshwar Foods Limited | 55 | |
Ashu Gupta | Sarveshwar Foods Limited | 56 | |
Seema Rani | Sarveshwar Foods Limited | 41 | |
Hirenkumar Shah | Vertoz Advertising Limited | 44 | |
Milan BCom | Foods Inns Limited | 62 | |
Surinder Arora | LT Foods Limited | 62 | |
Gurnam Arora | Kohinoor Foods Limited | 74 |
Management Performance
Return On Equity | 0.24 | ||||
Return On Asset | 0.15 |
Ajanta Pharma Limited Leadership Team
Elected by the shareholders, the Ajanta Pharma's board of directors comprises two types of representatives: Ajanta Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ajanta. The board's role is to monitor Ajanta Pharma's management team and ensure that shareholders' interests are well served. Ajanta Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ajanta Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pankaj Barbind, Deputy Sustainability | ||
Arvind Agrawal, Chief Officer | ||
Thampy Jacob, Senior HR | ||
Madhusudan Agrawal, Executive Board | ||
Rajesh MBA, Joint Director | ||
Madhusudan BSc, Executive Board | ||
Satish Pharm, President Operations | ||
Gaurang Shah, Company Legal | ||
Yogesh MBA, MD Director | ||
Com FCA, Chief Officer | ||
Nandkishore Agrawal, President Business | ||
Jagdish Joshi, Executive President |
Ajanta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ajanta Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.24 | ||||
Return On Asset | 0.15 | ||||
Profit Margin | 0.19 % | ||||
Operating Margin | 0.25 % | ||||
Current Valuation | 367.71 B | ||||
Shares Outstanding | 124.91 M | ||||
Shares Owned By Insiders | 66.47 % | ||||
Shares Owned By Institutions | 22.04 % | ||||
Price To Book | 10.18 X | ||||
Price To Sales | 8.35 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ajanta Stock
Ajanta Pharma financial ratios help investors to determine whether Ajanta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajanta with respect to the benefits of owning Ajanta Pharma security.